lobbying_activities: 1007086

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1007086	00247839-36cc-4722-ae60-7b947abe9afd	Q3	KAISER FOUNDATION HEALTH PLAN INC.	21027	KAISER FOUNDATION HEALTH PLAN INC	2010	third_quarter	PHA	S 726 Promoting Innovation and Access to Life-Saving Medicine Act To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other products. Sponsor: Schumer (D-NY)	Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office		180000	0	0	2010-10-19T17:31:02.267000-04:00